Next Article in Journal
L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model
Next Article in Special Issue
GLUT1 and TUBB4 in Glioblastoma Could be Efficacious Targets
Previous Article in Journal
Predictive Factors of Recurrence in Patients with Differentiated Thyroid Carcinoma: A Retrospective Analysis on 579 Patients
Previous Article in Special Issue
Antioxidant Defenses: A Context-Specific Vulnerability of Cancer Cells
Open AccessReview

Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment Resistance

Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, USA
*
Author to whom correspondence should be addressed.
Cancers 2019, 11(9), 1231; https://doi.org/10.3390/cancers11091231
Received: 19 June 2019 / Revised: 7 August 2019 / Accepted: 16 August 2019 / Published: 23 August 2019
(This article belongs to the Special Issue Metabolic Reprogramming and Vulnerabilities in Cancer)
Glioblastoma (GBM) is the most common and aggressive primary brain tumor and is nearly universally fatal. Targeted therapy and immunotherapy have had limited success in GBM, leaving surgery, alkylating chemotherapy and ionizing radiation as the standards of care. Like most cancers, GBMs rewire metabolism to fuel survival, proliferation, and invasion. Emerging evidence suggests that this metabolic reprogramming also mediates resistance to the standard-of-care therapies used to treat GBM. In this review, we discuss the noteworthy metabolic features of GBM, the key pathways that reshape tumor metabolism, and how inhibiting abnormal metabolism may be able to overcome the inherent resistance of GBM to radiation and chemotherapy. View Full-Text
Keywords: glioma; glioblastoma; metabolism; metabolic remodeling; metabolic targeting; radiation glioma; glioblastoma; metabolism; metabolic remodeling; metabolic targeting; radiation
Show Figures

Figure 1

MDPI and ACS Style

Zhou, W.; Wahl, D.R. Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment Resistance. Cancers 2019, 11, 1231.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop